Technologies

Life Sciences & Biotechnology

Title:

Indigenous Vccine Technology

Area:

Life Sciences & Biotechnology

Focus Area:

Vaccines, Infectious Diseases

Status:

Currently availble in Indian Market

Patent:

Nil

Social Benefits:

Considering the development of the indigenous HPV vaccine, India has the capacity to achieve success in the Cervical Cancer Elimination goal for 90% of coverage among girls up to 15 years old. With the introduction of the indigenous vaccine, the cost barrier being addressed.

Developing Agency:

Serum Institute, Pune

Brief Description

Description :

DBT-BIRAC-GCI supported Serum Institute of India for the first indigenously development of human papillomavirus vaccine (HPV)-- “CERVAVAC," against the cervical cancer in women

Related Technologies